Sign In
Buy CGC
$0.97
+0.0379 (+4.07%)
At Close: Aug 07, 2026
Canopy Growth Rallies On Possible Rescheduling Of Cannabis: Time To Buy
11:17pm, Monday, 04'th Sep 2023
Canopy Growth Corporation's stock price rallied nearly 50% based on the news that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III. Other Canadian canna
Time to Get High on Pot Stocks? (3 Catalysts)
10:33am, Friday, 01'st Sep 2023
When it comes to marijuana, a significant disconnect exists between the US government and the American people. Stock Strategist Andrew Rocco explains why the worst may be over for marijuana investors.
3 Cannabis Stocks Soaring on HHS' Recommendation to DEA
09:02am, Friday, 01'st Sep 2023
Canopy Growth (CGC), Tilray (TLRY) and Cronos (CRON) shoot up on news that the DEA is considering recommendations for low-risk reclassification of marijuana.
U.S. health officials want to loosen marijuana restrictions. Here's what it means
03:50pm, Thursday, 31'st Aug 2023
If marijuana is downgraded to a Schedule III drug, it could be a huge boost to a struggling industry.
Why Marijuana Stocks Are Glowing Green on Thursday
11:25am, Thursday, 31'st Aug 2023
The U.S. Department of Health and Human Services just recommended easing regulations on marijuana. The U.S. Drug Enforcement Agency may (or may not) take that advice.
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
10:40am, Thursday, 31'st Aug 2023
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q
Why Are Cannabis Stocks TLRY, ACB, CGC, CURLF Up Today?
09:52am, Thursday, 31'st Aug 2023
Cannabis stocks are up on Thursday as investors in the market react to news marijuana may be downgraded from a Schedule I drug. According to insiders, a member of the Department of Health and Human Se
Will a Change to US Marijuana Policy Save Any of the Weed Companies?
07:46am, Thursday, 31'st Aug 2023
The U.S. government appears finally to be ready to review its categorization of marijuana as a dangerous drug, reviving hope among investors and marijuana producers for an industry that took off like
Canopy Growth amends agreement to buy remaining stake of Les Serres Vert Cannabis
05:51pm, Wednesday, 30'th Aug 2023
Canopy Growth issued 15.2 million common shares to Les Serres Stephane Bertrand as part of an amended agreement for the Canadian cannabis company to buy a 45% stake in Les Serres Vert Cannabis.
Why Canopy Growth Stock Was on Fire Today
05:16pm, Wednesday, 30'th Aug 2023
According to a media report, a top federal health official has formally requested the reclassification of marijuana. This indicates high-level government support for drug law reform, at least for cann
Pot stocks jump as federal agency reportedly seeks to downgrade cannabis from the hard-drug category
03:57pm, Wednesday, 30'th Aug 2023
The Drug Enforcement Agency received an official recommendation to downgrade marijuana. Currently, pot is classified as a Schedule I drug, on par with heroin.
HHS calls for easing restrictions on marijuana, sending cannabis stocks higher
03:33pm, Wednesday, 30'th Aug 2023
That move could potentially expand the market for cannabis, sending shares of Canopy Growth, Tilray Brands and Cronos Group higher.
Top Marijuana Stocks To Watch Right Now 2023
07:00am, Wednesday, 30'th Aug 2023
Marijuana stock investors are consistently on watch for a rise in trading. The cannabis sector is an area of the stock market with more volatile trading than others. What this means is that without wa
3 Undervalued Cannabis Stocks With Sky-High Return Potential
09:42am, Tuesday, 29'th Aug 2023
AdvisorShares, the company managing the world's largest hemp exchange-traded fund Poseidon Dynamic Cannabis ETF (NYSEARCA:PSDN), has reported a waning interest in cannabis stocks. The cannabis industr
7 Stocks Sitting At 52-Week Lows Right Now
03:17pm, Thursday, 24'th Aug 2023
Winners and losers emerge from every earnings season. And this year's second quarter has been no different.
